
上市后監督總監

職位描述
工作職責:
This new position of Director, Post Market Surveillance (PMS) is accountable for overall strategy, execution and oversight of all activities associated with complaint handling associated quality management systems, functions and regulatory compliance reporting of Adverse Events (AEs) and Medical Device Reportable (MDRs) throughout the product life cycle for MicroPort Cardiovascular business, globally.
? This key leadership role is to ensure governmental regulatory requirements are met, customer experiences are appropriately logged and investigated to both comply with laws/regulations. This position will facilitate proactive quality and associated improvements in customer experience, as well as to ensure the organization is informed of adverse trending through analysis of complaints for Adverse Events, Medical Device Reportable, including tracking and trending.
? Direct leadership accountability and oversight of activities such as (a) uptake and logging of customer complaints, (b) their proper and thorough investigation and subsequent documentation, (c) statistical tracking and trending and associated evaluation and escalation of adverse customer complaint trends and early identification of new issues (with priority on safety issues), (d) proper evaluation of safety and patient risk through overall administration of a Health Hazard Evaluation (HHE) process, and (e) AE and MDR reporting, and the associated timeliness.
? Assures compliance with regards to AE/MDR with the applicable international regulatory requirements (ie, FDA QSRs, ISO 13485, Japanese MHLW, Brazilian ANVISA, EU MDR) for the company
s products, including medical devices, and combination products. Ensures successful internal and external inspections and audits.
? Ensure timeliness of all complaint handling, adverse events, and medical device reporting activities in accordance to procedures, standards and regulations.
? Responsible and accountable for the compliance of all PMS processes and procedures, associated document and performance metrics.
企業簡介
上海微創醫療器械(集團)有限公司為中國領先的醫療器械開發商、制造商及營銷商,主要專注于治療血管疾病及病變的微創介入產品。集團于2010年9月于香港聯合交易所上市,股份編號:00853。
集團主要供應心血管器械和其他血管器械以及糖尿病器械,主要產品為第二代鈷鉻合金藥物洗脫支架 Firebird 2。集團還供應其他血管支架,用于治療身體其他部位的血管疾病及失調。集團亦銷售極其細小的顱內支架、用于促進腦血管血液流量的靈活支架以及外科手術中使用的覆膜支架。
微創的產品于中國有逾1,100家醫院使用,部分產品出口至中國境外的20多個位于亞太地區(不包括中國)、南美及歐洲的國家。
有冠脈藥物支架系統、冠脈金屬支架系統、顱內動脈支架系統、腹主動脈瘤和胸主動脈瘤等支撐型人造血管支架、球囊(PTCA)擴張導管、導引導管及其相關附件、胰島素泵、骨科產品、射頻消融電生理導管等醫療器械;它們中絕大多數填補國內空白,被認定為上海市高新技術成果轉化項目,達國際先進水平,直接與國外產品競爭,已進入中國各大知名醫院,并出口日本、歐洲、拉美等國家與地區,具有一定的品牌知名度和市場占有率。
上海相關職位: 耗材市場經理 市場經理(耗材) 集采線項目經理 產品經理 醫學聯絡官(MSL) 醫學經理 醫藥代表-輔助生殖 輔助生殖醫藥代表 醫藥大區經理 學術推廣經理
熱門區域招聘: 重慶 北京 上海 浙江 江蘇 廣東 山東 湖南 安徽 河北
上海招聘企業: 易葫蘆(上海)醫藥科技有限公司 百進冠合(海南) 醫療科技有限公司 上海華茂藥業有限公司 上海信誼藥廠有限公司 上海強生制藥 歐姆龍健康醫療(中國)有限公司 青海瑞成藥業(集團)有限公司 上海交通大學醫學院附屬瑞金醫院 復旦大學附屬中山醫院 上海復星醫藥
職位發布日期: 2019-05-16